在非小细胞肺癌中的ivonescimab:协调免疫疗法和抗血管生成
Yan Zhang1, Xinyu Liu1, Shengxiang Ren1
1Department of Medical Oncology, Shanghai Pulmonary Hospital, Cancer Institute, Tongji University School of Medicine, Shanghai, China.
Expert opinion on biological therapy
|March 31, 2025
概括
一种新型双特异性抗体Ivonescimab结合了针对非小细胞肺癌 (NSCLC) 的免疫疗法和抗血管生成药物. 临床数据显示有希望的疗效和安全性,将其定位为未来癌症免疫治疗的潜在基石.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药理学 药理学是指药理学的学科.
背景情况:
- 免疫疗法和抗血管生成的联合治疗是癌症治疗的关键策略.
- 伊沃内西马布是第一个批准的双特异性抗体,其向免疫检查点抑制和血管生成.
- 这种双重向的方法比传统的组合疗法具有潜在的优势.
研究的目的:
- 审查ivonescimab的药理特征.
- 分析有关IVONESCIMAB在NSCLC治疗中的临床试验和数据.
- 讨论IVONESCIMAB在NSCLC中的临床前景和潜力.
主要方法:
- 对药理学数据的审查.
- 分析临床试验结果 (例如,HARMONi试验).
- 讨论安全性和有效性概况.
主要成果:
- 伊沃内西马布在治疗非小细胞肺癌 (NSCLC) 中显示出有前途的疗效.
- 这种药物表现出可管理的安全性.
- 通过单个双特异性抗体同时准免疫检查点和血管生成途径是一个重要的进步.
结论:
- 由于其双重向机制,Ivonescimab代表了NSCLC治疗的治疗进步.
- 有希望的疗效和安全数据表明,IVONESCIMAB可能会挑战目前的护理标准.
- 作为同类型的第一个双特异性抗体,ivonescimab可能会重新定义癌症免疫疗法范式.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


